These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6343339)

  • 1. Relative bioavailability of two sustained-release theophylline formulations versus an immediate-release preparation.
    Williams RL; Upton RA; Bostrom A
    J Asthma; 1983; 20(1):27-30. PubMed ID: 6343339
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: single and multiple dosing bioavailability studies.
    Saccar CL; Green LD; Helsel CL; Niehls ME; Diconcetto JA; Mansmann HC; McGeady SJ
    Ann Allergy; 1983 Apr; 50(4):245-8. PubMed ID: 6340563
    [No Abstract]   [Full Text] [Related]  

  • 3. Erratic absorption of a slow-release theophylline sprinkle product.
    Pedersen S; Møller-Petersen J
    Pediatrics; 1984 Oct; 74(4):534-8. PubMed ID: 6483520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of two controlled-release theophylline preparations.
    Fink JN; Levy MB; Conrad E
    Am J Med; 1985 Dec; 79(6A):58-61. PubMed ID: 4083301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and efficacy of a sustained-release theophylline tablet.
    Mitenko PA; Ogilvie RI
    Clin Pharmacol Ther; 1974 Oct; 16(4):720-6. PubMed ID: 4609343
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline absorption in young asthmatic children receiving sustained-release formulations.
    Haltom JR; Szefler SJ
    J Pediatr; 1985 Nov; 107(5):805-10. PubMed ID: 4056986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral bioavailability of slow-release theophylline from unencapsulated beads in preschool children with chronic asthma.
    Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Harris JB
    Ther Drug Monit; 1988; 10(4):395-400. PubMed ID: 3059587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two new controlled-release theophylline formulations in the management of asthma in children and reliability of salivary theophylline concentration.
    Boner AL; Bennati D; Miglioranzi P; Gaburro D
    J Asthma; 1986; 23(4):195-202. PubMed ID: 3531149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained release theophylline in nocturnal asthma.
    Elias-Jones AC; Higenbottam TW; Barnes ND; Godden DJ
    Arch Dis Child; 1984 Dec; 59(12):1159-61. PubMed ID: 6395810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of a once daily-administered theophylline preparation. A comparison study.
    Mangura BT; Maniatis T; Abdel Rahman MS; Bartholf R; Lavietes MH
    Chest; 1986 Oct; 90(4):566-70. PubMed ID: 3757567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of two Soviet sustained-release theophylline formulations in comparison with TheoDur.
    Kiivet RA; Teder P; Pruunsild T; Svensson JO
    Pharmacol Toxicol; 1992 Nov; 71(5):388-90. PubMed ID: 1448452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forty-eight-hour absorption pharmacokinetic profiles of two sustained-release theophylline preparations.
    Green LD; Saccar CL; Helsel CL; Niehls ME; McGeady SJ; Mansmann HC
    J Asthma; 1984; 21(1):35-9. PubMed ID: 6368520
    [No Abstract]   [Full Text] [Related]  

  • 14. Slow release theophylline in preschool asthmatics.
    Conway SP; Houlsby WT
    Arch Dis Child; 1986 Oct; 61(10):1024-6. PubMed ID: 3535686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.
    Giosue S; Bernocchi D; Parola D; Munno R; Mancini P
    J Int Med Res; 1987; 15(6):352-60. PubMed ID: 3325318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial of a sustained release theophylline tablet in adult asthmatics.
    Dhand R; Malik SK; Garg SK; Bhutani JK; Swaminathan S
    Indian J Chest Dis Allied Sci; 1986; 28(4):212-21. PubMed ID: 3301644
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum profile and bioavailability of a controlled-release theophylline formulation for once-daily use: comparison with a 12-hr preparation.
    Cohen BM
    J Asthma; 1984; 21(5):305-9. PubMed ID: 6389484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of steady state serum theophylline concentrations in healthy volunteers after dosing with Euphyllin retard and PulmiDur.
    Karlsson S; Lührmann B; Bahner ML; Schulz HU
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):342-6. PubMed ID: 3623739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state pharmacokinetics of two sustained-release theophylline products during once-daily and twice-daily dosing.
    Armstrong EP; Nako N; Plezia PM; Kramer TH; Jones WN
    Clin Pharm; 1987 Oct; 6(10):800-4. PubMed ID: 3505842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.